Hyperglycemia Induces Toll-Like Receptor Activity Through Increased Oxidative Stress

Metabolic Syndrome and Related Disorders

Volumn 14, Issue 5, 2016, Pages 239-241

  Pahwa, Roma ^a   Jialal, Ishwarlal ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; ANTIOXIDANT; AUTACOID; GLUCOSE BLOOD LEVEL; REACTIVE OXYGEN METABOLITE;

CAPILLARY ENDOTHELIAL CELL; CARDIAC MUSCLE CELL; CELL ADHESION; CYTOKINE RELEASE; DIABETIC CARDIOMYOPATHY; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; MONOCYTE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; ANALYSIS; ANIMAL; COMPLICATION; DIABETES MELLITUS; DIABETIC ANGIOPATHY; ENDOTHELIUM CELL; INFLAMMATION; METABOLISM; MICROCIRCULATION; PATHOPHYSIOLOGY;

ANIMALS; ANTIOXIDANTS; BLOOD GLUCOSE; DIABETES MELLITUS; DIABETIC ANGIOPATHIES; ENDOTHELIAL CELLS; HUMANS; HYPERGLYCEMIA; INFLAMMATION; INFLAMMATION MEDIATORS; MICROCIRCULATION; MONOCYTES; NADPH OXIDASE; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; TOLL-LIKE RECEPTORS;

EID: 84971265461     PISSN: 15404196     EISSN: 15578518     Source Type: Journal    
DOI: 10.1089/met.2016.29006.pah     Document Type: Review

References (26)

1. Brownlee M. The pathobiology of diabetic complications: A unifying mechanism. Diabetes 2005;54:1615-1625.
2. Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circ Res 2010;107:1058-1070.
3. Shanmugam N, Reddy MA, Guha M, et al. High glucose-induced expression of proinflammatory cytokine and chemokine genes in monocytic cells. Diabetes 2003;52: 1256-1264.
4. Dasu MR, Devaraj S, Zhao L, et al. High glucose induces toll-like receptor expression in human monocytes: Mechanism of activation. Diabetes 2008;57:3090-3098.
5. Yan SF, Ramasamy R, Schmidt AM. Mechanisms of disease: Advanced glycation endproducts and their receptor in inflammation and diabetes complications. Nat Clin Pract Endocrinol Metab 2008;4:285-293.
6. Lee AY, Chung SS. Contributions of polyol pathway to ox-idative stress in diabetic cataract. FASEB J 1999;13:23-30.
7. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001;414:813-820.
8. Akira S, Takeda K, Kaisho T. Toll-like receptors: Critical proteins linking innate and acquired immunity. Nat Immunol 2001;2:675-68.
9. Jialal I, Kaur H. The role of Toll-like receptors in diabetes-induced inflammation: Implications for vascular complications. Curr Diab Rep 2012;12:172-179.
10. Devaraj S, Jialal I, Yun JM, et al. Demonstration of increased toll-like receptor 2 and toll-like receptor 4 expression in monocytes of type 1 diabetes mellitus patients with microvascular complications. Metabolism 2011;60:256-259.
11. Dasu MR, Devaraj S, Park S, et al. Increased toll-like receptor (TLR) activation and TLR ligands in recently diagnosed type 2 diabetic subjects. Diabetes Care 2010;33: 4861-4868.
12. Liu ZW, Wang JK, Qiu C, et al. Matrinepretreatment improves cardiac function in rats with diabetic cardiomyop-athy via suppressing ROS/TLR-4 signaling pathway. Acta Pharmacol Sin 2015;36:323-333.
13. Dasu MR, Devaraj S. Jialal I. High glucose induces IL-1b expression in human monocytes: Mechanistic insights. Am J Physiol Endocrinol Metab 2007;293:E337-E346.
14. Nishikawa T, Edelstein D, Du XL, et al. Normalizing-mitochondrial superoxide production blocks three pathways of hyperglycemic damage. Nature 2000;404:787-790.
15. Kadri-Hassani N, Leger CL, Descomps B. The fatty acid bimodal action on superoxide production by human adherent monocytes under phorbol 12-myristate 13-acetate or diacylglycerol activation can be explained by the modulation of protein kinase C and p47phox translocation. J Biol Chem 1995;270:15111-15118.
16. Thallas-Bonke V, Thorpe SR, Coughlan MT, et al. Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-a-dependent pathway. Diabetes 2008;57:460-469.
17. Chen JX, Stinnett A. Critical role of the NADPH oxidase subunit p47phox on vascular TLR expression and neointi-mal lesion formation in high-fat diet-induced obesity. Lab Invest 2008;88:1316-1328.
18. Cha JJ, Hyun YY, Lee MH, et al. Renal protective effects of toll-like receptor signalling blockade in type 2 diabetic mice. Endocrinology 2013;154:2144-2155.
19. Rajamani U, Jialal I. Hyperglycemia induces Toll-like receptor-2 and-4 expression and activity in human mi-crovascular retinal endothelial cells: Implications for diabetic retinopathy. J Diabetes Res 2014;2014:790902.
20. Pahwa R, Nallasamy P, Jialal I. Toll-like receptors 2 and 4 mediate hyperglycemia induced macrovascular aortic endo-thelial cell inflammation and perturbation of the endo-thelialglycocalyx. J Diabetes Complications 2016. DOI: 10.1016/j.jdiacomp.2016.01.014. [Epub ahead of print].
21. Zhang B, Liu ZY, Li YY, et al. Anti-inflammatory effects of matrine in LPS-induced acute lung injury in mice. Eur J Pharm Sci 2011;44:573-579.
22. Dasu MR, Jialal I. Free fatty acids in the presence of high glucose amplify monocyte inflammation via Toll-like receptors. Am J Physiol Endocrinol Metab 2011;300:145-154.
23. Chen YY, Chen J, Hu JW, et al. Enhancement of lipopolysaccharide-induced toll-like receptor 2 expression and inflammatory cytokine secretion in HUVECs under high glucose conditions. Life Sci 2013;92:582-588.
24. Ghanim H, Sia CL, Upadhyay M, et al. Orange juice neutralizes the proinflam-matory effect of a high-fat, high-carbohydrate meal and prevents endotoxin increase and Tolllike receiver expression. J Clin Nutr 2010;91:940-949.
25. Gorin Y, Block K. Nox as a target for diabetic complications. Clin Sci (Lond) 2013;125:361-382.
26. Thallas-Bonke V, Jandeleit-Dahm KA, Cooper ME. Nox-4 and progressive kidney disease. Curr Opin Nephrol Hy-pertens 2015;24:74-80.